A randomized placebo controlled double blind crossover study of pioglitazone on left ventricular diastolic function in type 2 diabetes
International journal of cardiology, Volume 167, Issue 4, 2013, Pages 1329-1332.
diabetesdiastolic functionleft ventriclethiazolidinediones
Thiazolidinediones (TZDs), such as pioglitazone, are widely used to treat type 2 diabetes but there is evidence that their use is associated with an increased risk of heart failure. We compared the effect of pioglitazone vs. placebo on left ventricular (LV) diastolic and systolic function in people with type 2 diabetes.24 male or female p...More
Full Text (Upload PDF)
PPT (Upload PPT)